Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtype

This publication has 31 references indexed in Scilit:

• α₂‐Adrenoceptor subtypes and imidazoline‐like binding sites in the rat brain
  British Journal of Pharmacology, 1990
• The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes
  Journal of Neuroscience, 1988
• Clonidine binds to imidazole binding sites as well as α2-adrenoceptors in the ventrolateral medulla
  European Journal of Pharmacology, 1987
• A procedure for measuring α2-adrenergic receptor-mediated inhibition of cyclic AMP accumulation in rat brain slices
  Brain Research, 1986
• α ₂ -Adrenergic Mechanisms in Prefrontal Cortex Associated with Cognitive Decline in Aged Nonhuman Primates
  Science, 1985
• Heterogeneity of alpha-2 adrenergic receptors
  Pharmacology Biochemistry and Behavior, 1985
• Clonidine Ameliorates Gilles de la Tourette Syndrome
  Archives of General Psychiatry, 1980
• Aging in the Rhesus Monkey: Debilitating Effects on Short-term Memory
  Journal of Gerontology, 1978
• Clinical pharmacology and pharmacokinetics of clonidine
  Clinical Pharmacology & Therapeutics, 1976
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973